BioInformant

Your Global Leader in Stem Cell Market Research

Home » genetic testing

ORIG3N, Producing Patient-Specific iPS Cells – Interview with Robin Smith, CEO

By

ORIG3N ORIG3N, a biotechnology start-up headquartered in Boston, is attracting global attention for several reasons. First, it has created the world’s largest blood cell repository. ORIG3N is using these blood cells to produce patient-specific induced pluripotent stem cells (iPSCs), allowing the cells to be ever-renewing and giving rise to a living database of humanity known as LifeCapsule.

Second, the company has two other business segments, called LifeProfile and LifeSystems. These business units of ORIG3N help people to better understand the links between their genes and how their minds and bodies work.

Third, ORIG3N has identified HLA Superdonor matches for 90% of the U.S. population, positioning it to be custodians of this “first of a kind asset on planet earth.”

[Read more…]

PlumCare Announced Partnership With Cordlife and Additional Funding to Scale Operations

By

New agreement with Cordlife expands testing and monitoring service to eight new countries in Asia as company helps families make better decisions for their long term health

ALAMEDA, Calif., Feb. 28, 2018 — PlumCare, a DNA advisory service for families, today announced the company reached a partnership agreement with Cordlife Group Limited, a Singapore Exchange mainboard listed consumer healthcare company, as it expands access to the first-ever lifetime DNA testing and advisory service to help families take control of their health. To further support commercialization and access to its proprietary tests and services, PlumCare has secured an additional $750,000 in seed funding, with Steuart Ventures as the lead investor in this early stage financing round. [Read more…]

Pairing Cord Blood and Tissue Storage with Genetic Testing Services

By

One of the most prominent trends within the global cord blood banking industry is the pairing of cord blood and tissue storage with pre- and post-natal testing services, including genetic testing, genome sequencing, and metabolic screening services. The rise of this trend is driven by the ability of cord blood storage providers to offer complimentary services to existing clients, thereby expanding and diversifying their product portfolio.

As one cord blood executive recently told me, “They are looking to extend the relationship with the mother.”  [Read more…]

PerkinElmer Pairs Whole Genome Sequencing with Cord Blood and Tissue Banking

By

PerkinElmer Extends Clinical Whole Genome Sequencing Services

Provides Families a Novel, Personalized Approach to Managing their Health

WALTHAM, Mass.–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, expanded its Whole Genome Sequencing (WGS) services to families that preserve their cord blood and cord tissue with ViaCord. This launch follows the Company’s recent introduction of its clinical WGS services.

PerkinElmer Viacord Whole Genome Sequencing

Parents that choose ViaCord, PerkinElmer’s cord blood and cord tissue preservation business, now have the opportunity to benefit from a physician-ordered WGS test of their child’s DNA via a simple saliva test. The test examines a broad range of disease-related genes and provides diagnostic findings contributing to pediatric onset diseases. Additionally, the test reports on pharmacogenetic variants used to optimize certain drug selection.
[Read more…]

ORIG3N Executes DNA Testing on Nearly 450 XMed Attendees in Under 48 Hours

By

ORIG3N DNA TestingOne biotech company put the mission of this week’s Exponential Medicine Conference to work by proving that is is possible to deliver real-time, accurate DNA testing. Exponential Medicine is a unique four-day conference that gathers world-class faculty, innovators and entrepreneurs from across the biomedical and technology spectrum to “explore the convergence of fast moving technologies.” [Read more…]

BioInformant's World-Class Clients